Inhibition
11
0
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Cutaneous Silent Period-Based Comparison of DRG-PRF and TFESI in Lumbar Radicular Pain
The Effects of 8-week Resistance and Aerobic Exercise on Anxiety, Depression, Sleep, Inhibitory Control in Young Adults With Smartphone Overdependence
Brain Mechanisms of Overeating in Children
Effects of Cannabidiol (CBD) on the Brain
Yoga Practice, Stress and Cognitive Performance
Effects of Natural Sounds on Attention Restoration in Noisy Environment
Exploring the Impact of Biofeedback on the Inhibitory Control of Healthy Older Adults
Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
Pharmacokinetic Interactions of Metamizole (Dipyrone) in Healthy Subjects
Effect of Consumption on Cognitive Processes
Inhibition Transcranial Random Noise Stimulation